PARTNERS

Companies

Oncoxx and Capitank Pharma consortium

Member of the CAPITANK Pharma consortium

Oncoxx partner with Abnova

Monoclonal antibodies generation

Oncoxx partner with Roche
Oncoxx partner with Sigma-tau

Oncology, Roche

Rita de Santis, Head Immunology, Sigma-Tau

Oncoxx partner with Kinexus

Diagnostic platform

Oncoxx partner with JN Biosciences LLC

Monoclonal antibodies humanization

Oncoxx partner with Millipore

Antibody licensing to Millipore-Merck USA

Academia

Trop-2 function

Oncoxx and University of Cambridge in Trop-2 function
Oncoxx and Stanford School of Medicine in Trop-2 function
Oncoxx and Jefferson Kimmel Cancer Center in Trop-2 function
Oncoxx and Erasnus MC in Trop-2 function
Oncoxx and UCL MC in Trop-2 function

Therapy target

Oncoxx and Fondazione IRCCS in Therapy target
Oncoxx and Inserm in Therapy target
Oncoxx and University of California in Therapy target
Oncoxx and University of Milano in Therapy target
Oncoxx and University of Genova in Therapy target

Tumor marker

Oncoxx and Rush University in Tumor marker
Oncoxx and Taurinorum in Tumor marker
Oncoxx and Barensis Univ in Tumor marker
Oncoxx and York University in Tumor marker
Oncoxx and Ferrara University in Tumor marker
Oncoxx and Politecnica Marche University in Tumor marker
Oncoxx and Lille University in Tumor marker
Oncoxx and Pittsburgh University in Tumor marker
Oncoxx and Naples University in Tumor marker
Oncoxx and Prism in Tumor marker